(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial ...

Twin Peaks, a sports bar chain, made its debut on the Nasdaq Thursday, marking the first restaurant IPO of 2025.

Companies should not minimize the extent of a material cybersecurity incident by omitting material facts regarding the scope ...

Varindera Constructions and Sambhv Steel Tubes have received SEBI’s final observation to launch their IPOs. Varindera plans ...

Revenues reached AED 14.44 billion in financial year 2024, up 82% year-on-year. Net profit for the year rose 80% year-on-year ...

Twin Peaks – an American chain of sports bars and restaurants goes live on Nasdaq in what is the first restaurant debut of ...

Sahanand Medical Technologies (SMT), an Indian cardiovascular device maker backed by private equity firm Samara Capital, is ...

Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.

The lawyer behind a series of high-profile legal challenges to DEI practices is suing Bally’s and the city of Chicago over a $250 million IPO the suit says is unlawfully open only to people of color ...

The Madhya Pradesh-based plastic pipes manufacturer tapped capital markets to mobilise Rs 25.92 crore via initial share sale ...